Loading...
Loading...
Browse all stories on DeepNewz
VisitEli Lilly to Invest $1.8 Billion to Expand Drug Manufacturing in Ireland Facility
Sep 12, 2024, 09:32 AM
Eli Lilly, valued at $863.36 billion as of September 10, is making a significant investment to expand its manufacturing capabilities. The pharmaceutical giant announced a $1.8 billion investment to boost production of its blockbuster drugs for weight loss, diabetes, and Alzheimer's disease. This expansion includes a €927 million investment at its facility in Raheen, Limerick, Ireland, which will create 150 new jobs. The move underscores Lilly's commitment to addressing the growing demand for treatments in these critical areas.
View original story
Markets
No • 50%
Yes • 50%
Eli Lilly official announcements, press releases, or major news outlets
No • 50%
Yes • 50%
Eli Lilly official announcements, local news reports, employment data
Yes • 50%
No • 50%
Financial news websites, stock market data platforms
5-10% • 25%
15% or more • 25%
10-15% • 25%
0-5% • 25%
Eli Lilly's annual financial report, financial news websites
Increase by 0-10% • 25%
Decrease by more than 10% • 25%
Decrease by 0-10% • 25%
Increase by more than 10% • 25%
Stock market data platforms, financial news websites
Other • 25%
Weight loss drug • 25%
Diabetes drug • 25%
Alzheimer's drug • 25%
Eli Lilly official announcements, press releases, major news outlets